Zimmer Biomet Holdings Inventory Turnover Ratio 2006-2018 | ZBH

Current and historical inventory turnover ratio for Zimmer Biomet Holdings (ZBH) from 2006 to 2018. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Zimmer Biomet Holdings inventory turnover ratio for the three months ending September 30, 2018 was 0.24.
Zimmer Biomet Holdings Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.343B $7.824B
Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $125.111B 19.18
Abbott Laboratories (ABT) United States $123.927B 25.11
Stryker (SYK) United States $63.616B 23.98
Boston Scientific (BSX) United States $51.104B 25.83
Baxter (BAX) United States $32.759B 21.16
Smith & Nephew SNATS (SNN) United Kingdom $15.929B 0.00
ResMed (RMD) United States $14.783B 28.19
Canopy Growth (CGC) Canada $9.096B 0.00
Perrigo (PRGO) Ireland $8.909B 13.52
Bio-Rad Laboratories (BIO) United States $8.086B 51.70
Aurora Cannabis (ACB) Canada $6.688B 36.63
Hill-Rom Holdings (HRC) United States $6.277B 19.90
Haemonetics (HAE) United States $5.440B 47.85
Insulet (PODD) United States $4.849B 0.00
ICU Medical (ICUI) United States $4.490B 25.04
Hutchison China MediTech (HCM) China $4.221B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.051B 0.00
Agios Pharmaceuticals (AGIO) United States $3.732B 0.00
Neogen (NEOG) United States $3.281B 49.69
National Vision Holdings (EYE) United States $3.207B 70.82
NuVasive (NUVA) United States $2.954B 27.49
Aphria (APHA) $2.817B 0.00
Quidel (QDEL) United States $2.479B 32.31
NxStage Medical (NXTM) United States $1.925B 0.00
Phibro Animal Health (PAHC) United States $1.446B 20.47
AtriCure (ATRC) United States $1.192B 0.00
Cardiovascular Systems (CSII) United States $1.046B 1507.50
VAREX IMAGING (VREX) United States $1.018B 16.63
PetIQ (PETQ) United States $0.849B 27.76
Meridian Bioscience (VIVO) United States $0.828B 26.38
OraSure Technologies (OSUR) United States $0.826B 46.52
Surmodics (SRDX) United States $0.787B 120.33
Eagle Pharmaceuticals (EGRX) United States $0.753B 24.16
Cerus (CERS) United States $0.715B 0.00
MacroGenics (MGNX) United States $0.702B 0.00
Omeros (OMER) United States $0.628B 0.00
Owens & Minor (OMI) United States $0.575B 6.50
Lantheus Holdings (LNTH) United States $0.572B 17.69
Insys Therapeutics (INSY) United States $0.548B 0.00
LeMaitre Vascular (LMAT) United States $0.526B 25.81
NanoString Technologies (NSTG) United States $0.455B 0.00
TG Therapeutics (TGTX) United States $0.444B 0.00
Evolus (EOLS) United States $0.401B 0.00
Quanterix (QTRX) United States $0.362B 0.00
Utah Medical Products (UTMD) United States $0.325B 20.99
Cytosorbents (CTSO) United States $0.306B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.266B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
BioLife Solutions (BLFS) United States $0.214B 289.75
Bovie Medical (BVX) United States $0.204B 0.00
Rockwell Medical (RMTI) United States $0.201B 0.00
Chimerix (CMRX) United States $0.162B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.156B 0.00
Fonar (FONR) United States $0.141B 7.11
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.091B 0.00
United-Guardian (UG) United States $0.079B 16.60
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.67
InfuSystems Holdings (INFU) United States $0.060B 0.00
CAS Medical Systems (CASM) United States $0.055B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
Capricor Therapeutics (CAPR) United States $0.029B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Myomo (MYO) United States $0.024B 0.00
Senestech (SNES) United States $0.020B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00